NO313673B1 - Stabil krystallinsk (6S)- og (6R)-tetrahydrofolsyre, fremgangsmåte for fremstilling derav og farmasöytisk preparat - Google Patents

Stabil krystallinsk (6S)- og (6R)-tetrahydrofolsyre, fremgangsmåte for fremstilling derav og farmasöytisk preparat Download PDF

Info

Publication number
NO313673B1
NO313673B1 NO19951796A NO951796A NO313673B1 NO 313673 B1 NO313673 B1 NO 313673B1 NO 19951796 A NO19951796 A NO 19951796A NO 951796 A NO951796 A NO 951796A NO 313673 B1 NO313673 B1 NO 313673B1
Authority
NO
Norway
Prior art keywords
tetrahydrofolic acid
crystalline
acid
crystallization
value
Prior art date
Application number
NO19951796A
Other languages
English (en)
Norwegian (no)
Other versions
NO951796L (no
NO951796D0 (no
Inventor
Hans-Rudolf Mueller
Martin Ulmann
Rudolf Moser
Thomas Ammann
Original Assignee
Eprova Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4210562&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO313673(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eprova Ag filed Critical Eprova Ag
Publication of NO951796D0 publication Critical patent/NO951796D0/no
Publication of NO951796L publication Critical patent/NO951796L/no
Publication of NO313673B1 publication Critical patent/NO313673B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/02Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Transplantation (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO19951796A 1994-05-09 1995-05-08 Stabil krystallinsk (6S)- og (6R)-tetrahydrofolsyre, fremgangsmåte for fremstilling derav og farmasöytisk preparat NO313673B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH144294A CH686369A5 (de) 1994-05-09 1994-05-09 Stabile kristalline (6S)- und (6R)-Tetrahydrofolseure.

Publications (3)

Publication Number Publication Date
NO951796D0 NO951796D0 (no) 1995-05-08
NO951796L NO951796L (no) 1995-11-10
NO313673B1 true NO313673B1 (no) 2002-11-11

Family

ID=4210562

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19951796A NO313673B1 (no) 1994-05-09 1995-05-08 Stabil krystallinsk (6S)- og (6R)-tetrahydrofolsyre, fremgangsmåte for fremstilling derav og farmasöytisk preparat

Country Status (19)

Country Link
US (2) US6271374B1 (xx)
EP (1) EP0682026B2 (xx)
JP (2) JP3419585B2 (xx)
KR (1) KR950032192A (xx)
CN (1) CN1063444C (xx)
AT (1) ATE188699T1 (xx)
AU (1) AU704363B2 (xx)
CA (1) CA2148671C (xx)
CH (1) CH686369A5 (xx)
DE (1) DE59507591D1 (xx)
DK (1) DK0682026T4 (xx)
ES (1) ES2144066T5 (xx)
FI (1) FI120585B (xx)
GR (1) GR3032984T3 (xx)
HU (1) HUT71612A (xx)
NO (1) NO313673B1 (xx)
PT (1) PT682026E (xx)
RU (1) RU2165422C2 (xx)
ZA (1) ZA953673B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689831A5 (de) * 1995-11-07 1999-12-15 Eprova Ag Stabile kristalline Tetrahydrofolsaeure-Salze.
CH693905A5 (de) * 1999-04-15 2004-04-15 Eprova Ag Stabile kristalline Salze von 5-Methyltetrahydrofolsäure.
CH695217A5 (de) * 1999-07-14 2006-01-31 Merck Eprova Ag Verfahren zur Trennung optischer Isomeren von Tetrahydrofolsäureestersalzen und Tetrahydrofolsäure.
CH694251A5 (de) * 1999-07-14 2004-10-15 Eprova Ag Herstellung von Tetrahydropterin und Derivaten.
ITMI20020132A1 (it) 2002-01-25 2003-07-25 Gmt Fine Chemicals Sa Processo per l'ottenimento dell'acido (6s)-5,6,7,8-tetraidrofolico
DK1708690T3 (en) 2003-11-17 2016-11-07 Biomarin Pharm Inc TREATMENT OF PHENYLKETONURI WITH BH4
KR20060051135A (ko) * 2004-09-15 2006-05-19 니프로 가부시키가이샤 안정화된 주사용 수용액 제재
AU2005313940A1 (en) * 2004-12-08 2006-06-15 Biomarin Pharmaceutical Inc. Methods and compositions for the treatment of pulmonary hypertension of the newborn
AU2010271178B2 (en) 2009-07-10 2015-10-22 Linzy O. Scott Iii Methods and compositions for treating thyroid-related medical conditions with reduced folates
EP3949973A3 (en) 2010-02-12 2022-07-06 Gentelon, Inc. Compositions and methods for treating depression
WO2013163917A1 (zh) 2012-04-13 2013-11-07 连云港金康和信药业有限公司 化合物jk12a及其制备
US9492421B1 (en) 2013-11-14 2016-11-15 Argent Development Group, Llc Nutritional supplements for treatment of iron deficiency anemia
US9629846B1 (en) 2013-11-14 2017-04-25 Argent Development Group, Llc Nutritional supplements for women desiring to become pregnant, and pregnant and nursing women
WO2016185413A1 (en) 2015-05-20 2016-11-24 Nestec S.A. Modified release formulations
US10059710B2 (en) * 2016-02-17 2018-08-28 Merck & Cie Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid
AU2017397463B2 (en) 2016-11-03 2022-01-06 HedoniaUSA, Inc. Compositions and methods for treating depression
WO2018178144A1 (en) 2017-03-31 2018-10-04 Merck Patent Gmbh Crystalline sodium salt of 5-methyl-(6s)-tetrahydrofolic acid
JP7285785B2 (ja) 2017-03-31 2023-06-02 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 5-メチル-(6s)-テトラヒドロ葉酸の結晶性ナトリウム塩

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS497416A (xx) * 1972-05-12 1974-01-23
CH673459A5 (xx) * 1987-05-15 1990-03-15 Eprova Ag
DE3821875C1 (xx) * 1988-06-29 1990-02-15 Eprova Ag, Forschungsinstitut, Schaffhausen, Ch
ATE139799T1 (de) * 1989-12-11 1996-07-15 American Cyanamid Co Verfahren zur herstellung von optisch reinen diastereoisomeren von tetrahydrofolatverbindungen
CH681303A5 (xx) * 1991-01-16 1993-02-26 Eprova Ag
US5198547A (en) * 1992-03-16 1993-03-30 South Alabama Medical Science Foundation, Usa Process for N5-formylating tetrahydropteridines
US5698693A (en) * 1992-11-16 1997-12-16 The United States Of America As Represented By The Department Of Health And Human Services Process of separating the diastereomers of (6R,6S) -5,6,7,8-tetrahydrofolic acid derivatives
CH686672A5 (de) * 1992-12-01 1996-05-31 Cerbios Pharma Sa Verfahren zur Herstellung von (6S)-5,6,7,8-Tetrahydrofolsaeure.
WO2001070922A1 (en) 2000-03-21 2001-09-27 Bbj Environmental Solutions Inc. Aqueous cleaning composition with controlled ph

Also Published As

Publication number Publication date
ZA953673B (en) 1996-01-12
JP3419585B2 (ja) 2003-06-23
FI952198A (fi) 1995-11-10
CN1063444C (zh) 2001-03-21
DK0682026T3 (da) 2000-04-17
CN1122337A (zh) 1996-05-15
US6271374B1 (en) 2001-08-07
PT682026E (pt) 2000-05-31
HUT71612A (en) 1996-01-29
ES2144066T5 (es) 2003-11-01
JP4898081B2 (ja) 2012-03-14
AU1793195A (en) 1995-11-16
US6596721B2 (en) 2003-07-22
RU95107144A (ru) 1997-03-20
US20010002398A1 (en) 2001-05-31
RU2165422C2 (ru) 2001-04-20
CH686369A5 (de) 1996-03-15
FI952198A0 (fi) 1995-05-08
EP0682026B1 (de) 2000-01-12
JPH0841062A (ja) 1996-02-13
JP2003201291A (ja) 2003-07-18
DK0682026T4 (da) 2003-02-24
FI120585B (fi) 2009-12-15
EP0682026A1 (de) 1995-11-15
CA2148671A1 (en) 1995-11-10
KR950032192A (ko) 1995-12-20
CA2148671C (en) 2000-08-15
GR3032984T3 (en) 2000-07-31
ATE188699T1 (de) 2000-01-15
NO951796L (no) 1995-11-10
ES2144066T3 (es) 2000-06-01
DE59507591D1 (de) 2000-02-17
NO951796D0 (no) 1995-05-08
AU704363B2 (en) 1999-04-22
EP0682026B2 (de) 2003-02-05

Similar Documents

Publication Publication Date Title
NO313673B1 (no) Stabil krystallinsk (6S)- og (6R)-tetrahydrofolsyre, fremgangsmåte for fremstilling derav og farmasöytisk preparat
NO325495B1 (no) Stabile, krystallinske salter av 5-metyltetrahydrofolsyre og fremgangsmate til fremstilling derav
NO301422B1 (no) Fremgangsmåte for fremstilling av (6S)- og (6R)-tetrahydrofolsyre
JPH0826022B2 (ja) テトラヒドロ葉酸類の製造方法
US5010194A (en) Method for the resolution of folinic acid
RU2187508C2 (ru) Стабильные кристаллические соли тетрагидрофолиевой кислоты (варианты), способ их получения и фармацевтическая композиция
US5300505A (en) Stable salts of 5,10-methylenetetrahydrofolic acid
EP2254890B1 (en) Process for the diastereoisomeric resolution of 5-methyltetrahydrofolic acid
US20080153849A1 (en) Process for the Preparation of Crystalline (6Rrs)-N(5)-Formyl-5,6,7,8-Tetrahydrofolic Acid
CH686672A5 (de) Verfahren zur Herstellung von (6S)-5,6,7,8-Tetrahydrofolsaeure.

Legal Events

Date Code Title Description
MK1K Patent expired